PMC:7189872 / 23953-24457
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 446 | 164-167 | Gene | denotes | MHC | Gene:3107 |
| 447 | 168-171 | Gene | denotes | HLA | Gene:3123 |
| 448 | 76-86 | Species | denotes | SARS-COV-2 | Tax:2697049 |
| 449 | 323-333 | Species | denotes | SARS-COV-2 | Tax:2697049 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T220 | 164-167 | Body_part | denotes | MHC | http://purl.org/sig/ont/fma/fma84079 |
| T221 | 168-171 | Body_part | denotes | HLA | http://purl.org/sig/ont/fma/fma84795 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T41 | 76-80 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T42 | 323-327 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T184 | 58-59 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T185 | 112-115 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T186 | 144-150 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
| T187 | 185-188 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T188 | 269-276 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptide |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T187 | 10-17 | Chemical | denotes | epitope | http://purl.obolibrary.org/obo/CHEBI_53000 |
| T188 | 104-111 | Chemical | denotes | epitope | http://purl.obolibrary.org/obo/CHEBI_53000 |
| T189 | 269-276 | Chemical | denotes | peptide | http://purl.obolibrary.org/obo/CHEBI_16670 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T201 | 0-87 | Sentence | denotes | ITLCFTLKR epitope was selected for crafting and designing a vaccine against SARS-COV-2. |
| T202 | 88-252 | Sentence | denotes | This particular epitope has good antigenicity, exhibits active binding with MHC HLA-Alleles, and has maximum population coverage for different geographical regions. |
| T203 | 253-361 | Sentence | denotes | Therefore, this peptide can be further used in vaccine design against SARS-COV-2 after wet lab verification. |
| T204 | 362-504 | Sentence | denotes | This novel approach can also assist life science research groups to reduce time, monetary expenditures, as well as physical hit-trial efforts. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T459 | 10-17 | BV_9 | denotes | epitope |
| T460 | 76-86 | SP_7 | denotes | SARS-COV-2 |
| T461 | 104-111 | BV_9 | denotes | epitope |
| T462 | 164-167 | GO:0042611 | denotes | MHC |
| T463 | 172-179 | SO:0001023 | denotes | Alleles |
| T464 | 300-314 | BV_26 | denotes | vaccine design |
| T465 | 323-333 | SP_7 | denotes | SARS-COV-2 |
| T466 | 398-402 | UBERON:0000104 | denotes | life |
| T16915 | 323-333 | SP_7 | denotes | SARS-COV-2 |
| T18374 | 10-17 | BV_9 | denotes | epitope |
| T95440 | 76-86 | SP_7 | denotes | SARS-COV-2 |
| T19239 | 104-111 | BV_9 | denotes | epitope |
| T52484 | 164-167 | GO:0042611 | denotes | MHC |
| T40017 | 172-179 | SO:0001023 | denotes | Alleles |
| T51478 | 300-314 | BV_26 | denotes | vaccine design |
| T11973 | 323-333 | SP_7 | denotes | SARS-COV-2 |
| T50614 | 398-402 | UBERON:0000104 | denotes | life |